Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1996-10-4
pubmed:abstractText
We studied the effects of high-dose methylprednisolone on the survival of intrastriatal neural xenografts and the host responses against them. Dissociated mesencephalic tissue from inbred mouse (CBA-strain) embryos was transplanted to the intact striatum of adult Sprague-Dawley rats. The rats received either daily injections of methylprednisolone (30 mg/kg), or cyclosporin A (10 mg/kg), or no immunosuppressive treatment. Two or six weeks after transplantation, there was good survival of xenografts in both the methylprednisolone- and cyclosporin A-treated rats. In contrast, the xenografts in untreated control rats were all rejected by six weeks. There was no marked difference in the degree of expression of MHC class I and II antigens and the accumulation of activated astrocytes and microglial cells/macrophages between the three groups. However, both methylprednisolone and cyclosporin A reduced infiltration of T lymphocytes to the transplantation sites. The expression of pro-inflammatory cytokines (interferon-gamma, tumour necrosis factor-alpha, interleukin-6) in and around the grafts was lower in the methylprednisolone- and cyclosporin A-treated groups than in untreated control rats. Although high-dose methylprednisolone caused significant body weight loss, we conclude that this treatment can prevent rejection of intrastriatal grafts of xenogeneic embryonic neural tissue in the adult.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0006-8993
pubmed:author
pubmed:issnType
Print
pubmed:day
18
pubmed:volume
712
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
199-212
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8814894-Animals, pubmed-meshheading:8814894-Brain Chemistry, pubmed-meshheading:8814894-Brain Tissue Transplantation, pubmed-meshheading:8814894-CD4-CD8 Ratio, pubmed-meshheading:8814894-Cytokines, pubmed-meshheading:8814894-Female, pubmed-meshheading:8814894-Fetal Tissue Transplantation, pubmed-meshheading:8814894-Glial Fibrillary Acidic Protein, pubmed-meshheading:8814894-Graft Rejection, pubmed-meshheading:8814894-Graft Survival, pubmed-meshheading:8814894-Immunohistochemistry, pubmed-meshheading:8814894-Immunosuppressive Agents, pubmed-meshheading:8814894-Major Histocompatibility Complex, pubmed-meshheading:8814894-Methylprednisolone, pubmed-meshheading:8814894-Mice, pubmed-meshheading:8814894-Neostriatum, pubmed-meshheading:8814894-Pregnancy, pubmed-meshheading:8814894-Rats, pubmed-meshheading:8814894-Rats, Sprague-Dawley, pubmed-meshheading:8814894-Receptors, Complement, pubmed-meshheading:8814894-Transplantation, Heterologous, pubmed-meshheading:8814894-Tyrosine 3-Monooxygenase
pubmed:year
1996
pubmed:articleTitle
Methylprednisolone prevents rejection of intrastriatal grafts of xenogeneic embryonic neural tissue in adult rats.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't